Most common adverse events at least possibly related to treatment (percent of patients having event)
Adverse event . | Grade . | |||
---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | |
Thrombocytopenia | 23 | 18 | 18 | 9 |
Anemia | 9 | 55 | 5 | 0 |
Neutropenia | 5 | 14 | 27 | 18 |
Rash | 18 | 23 | 18 | 0 |
Edema | 18 | 27 | 9 | 0 |
Infection | 0 | 27 | 18 | 0 |
Constipation | 27 | 9 | 0 | 0 |
Diarrhea | 27 | 14 | 0 | 0 |
Dyspnea | 27 | 5 | 9 | 0 |
Fatigue | 0 | 14 | 18 | 0 |
AST | 14 | 9 | 5 | 0 |
Hypocalcemia | 0 | 14 | 9 | 0 |
Elevated creatinine level | 9 | 14 | 0 | 0 |
Low consciousness/cognitive disorder | 0 | 14 | 5 | 0 |
Neurosensory | 23 | 0 | 0 | 0 |
Elevated alkaline phosphatase/bilirubin level | 0 | 0 | 5 | 0 |
Dyspepsia | 0 | 5 | 9 | 0 |
Hyperkalemia | 0 | 9 | 0 | 0 |
Hypothyroidism | 5 | 5 | 0 | 0 |
Muscle weakness | 0 | 14 | 0 | 0 |
Thrombosis | 0 | 0 | 9 | 0 |
Adverse event . | Grade . | |||
---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | |
Thrombocytopenia | 23 | 18 | 18 | 9 |
Anemia | 9 | 55 | 5 | 0 |
Neutropenia | 5 | 14 | 27 | 18 |
Rash | 18 | 23 | 18 | 0 |
Edema | 18 | 27 | 9 | 0 |
Infection | 0 | 27 | 18 | 0 |
Constipation | 27 | 9 | 0 | 0 |
Diarrhea | 27 | 14 | 0 | 0 |
Dyspnea | 27 | 5 | 9 | 0 |
Fatigue | 0 | 14 | 18 | 0 |
AST | 14 | 9 | 5 | 0 |
Hypocalcemia | 0 | 14 | 9 | 0 |
Elevated creatinine level | 9 | 14 | 0 | 0 |
Low consciousness/cognitive disorder | 0 | 14 | 5 | 0 |
Neurosensory | 23 | 0 | 0 | 0 |
Elevated alkaline phosphatase/bilirubin level | 0 | 0 | 5 | 0 |
Dyspepsia | 0 | 5 | 9 | 0 |
Hyperkalemia | 0 | 9 | 0 | 0 |
Hypothyroidism | 5 | 5 | 0 | 0 |
Muscle weakness | 0 | 14 | 0 | 0 |
Thrombosis | 0 | 0 | 9 | 0 |